- Home
- KMB vs HBANZ Comparison
KMB vs HBANZ Comparison
Compare KMB & HBANZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMB | HBANZ |
|---|---|---|
| Founded | 1910 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Major Banks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.2B | 33.4B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | KMB | HBANZ |
|---|---|---|
| Price | $98.52 | $20.91 |
| Analyst Decision | Hold | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $122.25 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 25.4K |
| Earning Date | 04-21-2026 | N/A |
| Dividend Yield | ★ 5.19% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.07 | N/A |
| Revenue | ★ $16,447,000,000.00 | N/A |
| Revenue This Year | $3.90 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $16.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $96.26 | $20.85 |
| 52 Week High | $147.12 | $22.23 |
Technical Indicators
Market Signals| Indicator | KMB | HBANZ |
|---|---|---|
| Relative Strength Index (RSI) | 33.99 | 32.47 |
| Support Level | $97.86 | N/A |
| Resistance Level | $102.54 | $21.71 |
| Average True Range (ATR) | 2.02 | 0.16 |
| MACD | -0.77 | -0.07 |
| Stochastic Oscillator | 7.58 | 0.00 |
Price Performance
Historical ComparisonAbout KMB Kimberly-Clark Corporation
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.